SCHEMBL24993602

SCHEMBL24993602

COC(=O)c1nccnc1Oc1ccc(OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 2/20 0.45
THRB P10828 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 2/20 0.43
MAPK8 P45983 1/20 0.43
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15912474 0.88 TDP1 (0.48) TDP1LMNASMN1; SMN2TP53L3MBTL1
SCHEMBL24993325 0.83 CA1 (0.53) CA1CA2LMNASMN1; SMN2ALDH1A1
SCHEMBL871874 0.82 HTT (0.49) CA1CA2LMNASMN1; SMN2ALDH1A1
SCHEMBL31214279 0.81 NPSR1 (0.48) TDP1CA1CA2ALDH1A1KDM4E
SCHEMBL958881 0.81 NPSR1 (0.48) TDP1CA1CA2ALDH1A1KDM4E
SCHEMBL2488376 0.79
SCHEMBL24994333 0.77 KDM4E (0.51) CA1CA2CYP1A2CYP2C9CYP2C19
SCHEMBL71518 0.74 NPSR1 (0.59) TDP1CA1CA2SMN1; SMN2ALDH1A1
SCHEMBL9085493 0.74 ALDH1A1 (0.46) TDP1CYP1A2LMNASMN1; SMN2ALDH1A1
SCHEMBL8340364 0.74 P2RY1 (0.59) CYP1A2CYP2C19KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 WO disclosed